Assignee
HANGZHOU XINGAO BIOTECHNOLOGY CO LTD
CN·1 granted patent·4 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
5 records- 0144US2024238201A1Liposome carrier-based multi-target complex, drug delivery platform containing the same, and application thereofHANGZHOU XINGAO BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0241US2024317792A1Cyclic dinucleotide metal compound, and preparation and application thereofHANGZHOU XINGAO BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0337US2021023115A1Composition of anti-tumor compound drug and application thereof in fighting tumorsHANGZHOU XINGAO BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 0436US12508323B2Method of treatment of colorectal, breast and lung cancer with metal containing immune agonist complexesHANGZHOU XINGAO BIOTECHNOLOGY CO LTD·Filed 2022·Granted Dec 30, 2025·0 cites·2 claims
- 0527US2020377545A1Novel anti-tumor compound and application thereof in preparing anti-tumor drugsHANGZHOU XINGAO BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANGZHOU XINGAO BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →